Cargando…

Targeting FTO for cancer therapy and more

Detalles Bibliográficos
Autores principales: Qing, Ying, Su, Rui, Chen, Jianjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386555/
https://www.ncbi.nlm.nih.gov/pubmed/34382944
http://dx.doi.org/10.18632/aging.203404
_version_ 1783742283902877696
author Qing, Ying
Su, Rui
Chen, Jianjun
author_facet Qing, Ying
Su, Rui
Chen, Jianjun
author_sort Qing, Ying
collection PubMed
description
format Online
Article
Text
id pubmed-8386555
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-83865552021-08-27 Targeting FTO for cancer therapy and more Qing, Ying Su, Rui Chen, Jianjun Aging (Albany NY) Editorial Impact Journals 2021-08-11 /pmc/articles/PMC8386555/ /pubmed/34382944 http://dx.doi.org/10.18632/aging.203404 Text en Copyright: © 2021 Qing et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Qing, Ying
Su, Rui
Chen, Jianjun
Targeting FTO for cancer therapy and more
title Targeting FTO for cancer therapy and more
title_full Targeting FTO for cancer therapy and more
title_fullStr Targeting FTO for cancer therapy and more
title_full_unstemmed Targeting FTO for cancer therapy and more
title_short Targeting FTO for cancer therapy and more
title_sort targeting fto for cancer therapy and more
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386555/
https://www.ncbi.nlm.nih.gov/pubmed/34382944
http://dx.doi.org/10.18632/aging.203404
work_keys_str_mv AT qingying targetingftoforcancertherapyandmore
AT surui targetingftoforcancertherapyandmore
AT chenjianjun targetingftoforcancertherapyandmore